Antag Therapeutics secures €80 million Series A financing EP News Bureau Dec 5, 2024 Funds to advance AT-7687 and expand obesity treatment pipeline
India will transform into a global biomanufacturing hub: Dr Jitendra Singh EP News Bureau Oct 18, 2024 Union Minister facilitated an exchange of MoU and technology transfer between NIIST and various technological institutions across…
Top 20 global biopharma companies report 4.3% growth in market capitalisation in Q2 2024, reveals… GlobalData Aug 16, 2024 Biopharma sector sees market capitalisation rise to $4 trillion, driven by strong performances from Lilly, Novo Nordisk, and…
The politics of health: how elections will impact on life sciences Ivor Campbell Jul 25, 2024 Ivor Campbell, Chief Executive, Snedden Campbell, a specialist recruitment consultant for the medical technology industry…
Empowering Biopharma Innovation: The role of startups, incubators, and investment trends EP News Bureau Jul 22, 2024 Dr Samir Vyas, PhD, Country General Manager - India, Agilent, highlights how Indian startups are attracting venture capital for…
Sanofi announces expansion of its Global Capacity Center in Hyderabad EP News Bureau Jul 18, 2024 Plans €400 million investment by 2030, with €100 million by 2025; expanded center will host up to 2600 employees
Life sciences industry forecasts significant revenue from connected health within 5 years EP News Bureau Jun 19, 2024 Biopharma sees a sixfold surge in market-ready connected health products since 2021
Plasmagen Biosciences taps into the niche Indian biopharma market with the launch of CSL’s… EP News Bureau Jun 19, 2024 Haemocomplettan P will cater to the 1,50,000 cardiac surgeries and over 1,800 liver transplant patients who are at risk of massive…
Ascentage Pharma signs option agreement with Takeda EP News Bureau Jun 17, 2024 Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other than China and a few…
Biotech funding set for recovery in 2024: GlobalData EP News Bureau Mar 13, 2024 This optimism follows a downturn in private biotech venture financing, where funding in 2023 declined by 43.2 per cent and 52.3…